Full access
Clinical & Research News
Published Online: 18 May 2007

Bipolar Patients on Lithium Show Brain-Tissue Growth

Mark MoranAuthors Info & Affiliations
Publication: Psychiatric News
Volume 42, Number 10
https://doi.org/10.1176/pn.42.10.0035
Lithium appears to increase gray matter in the brains of patients who use the drug, according to a report that will appear in Biological Psychiatry in July.
In a statement about the study released prior to publication, neuroscientists at UCLA said they have shown that lithium, long the standard treatment for bipolar disorder, increases the amount of gray matter in the brains of patients with the illness.
“Bipolar patients who were taking lithium had a striking increase in gray matter in the cingulate and paralimbic regions of the brain,” Carrie Bearden, Ph.D., a clinical neuropsychologist and assistant professor of psychiatry at UCLA said in the statement. “These regions regulate attention, motivation, and emotion, which are profoundly affected in bipolar illness.”
In this study, Bearden and colleagues at UCLA used computer analysis to analyze brain scans collected by collaborators at the University of Pittsburgh in order to determine whether bipolar patients showed changes in brain tissue and, if so, whether those changes were influenced by lithium treatment.
They employed high-resolution MRI and cortical pattern-matching methods to map gray-matter differences in 28 adults with bipolar disorder — 70 percent of whom were treated with lithium—and 28 healthy control subjects. Detailed spatial analyses of gray-matter distribution were conducted by measuring local volumes of gray matter at thousands of locations in the brain.
While the brains of lithium-treated bipolar patients did not differ from those of the control subjects in total white-matter volume, their overall gray-matter volume was significantly higher, sometimes by as much as 15 percent.
Although other studies have measured increases in the overall volume of the brain, Bearden said, this imaging method allowed the researchers to see exactly which brain regions were affected by lithium. These new findings suggest that lithium may work by increasing the amount of gray matter in particular brain areas, which in turn suggests that existing gray matter in these regions of bipolar brains may be underused or dysfunctional.
Bearden added that there is no evidence that the increase in gray matter persists if lithium treatment is discontinued. “But it does suggest that lithium can have dramatic effects on gray matter in the brain,” she said. “This may be an important clue as to how and why it works.”▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 42 • Number 10 • May 18, 2007
Pages: 35

History

Published online: 18 May 2007
Published in print: May 18, 2007

Notes

Patients on lithium had significant increase in the cingulate and paralimbic regions of the brain, which regulate attention and emotion.

Authors

Affiliations

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.